AMP-activated protein kinase: a potential player in Alzheimer's disease.
about
New Potential Pharmacological Functions of Chinese Herbal Medicines via Regulation of AutophagyAMP-activated protein kinase: a target for drugs both ancient and modernNew Insights for Oxidative Stress and Diabetes MellitusGut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutideThiopental inhibits global protein synthesis by repression of eukaryotic elongation factor 2 and protects from hypoxic neuronal cell deathEnhanced expression of WD repeat-containing protein 35 via CaMKK/AMPK activation in bupivacaine-treated Neuro2a cellsEstrogen: a master regulator of bioenergetic systems in the brain and bodyAMPK activation--protean potential for boosting healthspan.Leptin: new hope for the treatment of post-operative cognitive dysfunction?Treadmill exercise ameliorates the regulation of energy metabolism in skeletal muscle of NSE/PS2m-transgenic mice with Alzheimer's disease.Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid β.Taking aim at Alzheimer's disease through the mammalian target of rapamycinInsulin resistance in Alzheimer's disease.Deficient hippocampal insulin signaling and augmented Tau phosphorylation is related to obesity- and age-induced peripheral insulin resistance: a study in Zucker rats.A systems biology investigation of neurodegenerative dementia reveals a pivotal role of autophagy.Effects of discontinuing a high-fat diet on mitochondrial proteins and 6-hydroxydopamine-induced dopamine depletion in rats.Bioenergy sensing in the brain: the role of AMP-activated protein kinase in neuronal metabolism, development and neurological diseasesModulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer's DiseaseAdenosine monophosphate-activated protein kinase activation mediates the leptin-induced attenuation of cognitive impairment in a streptozotocin-induced rat modelRare Earth Ion Mediated Fluorescence Accumulation on a Single Microbead: An Ultrasensitive Strategy for the Detection of Protein Kinase Activity at the Single-Cell Level.Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPKSer-485 PhosphorylationPrevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL.Targeting AMPK: From Ancient Drugs to New Small-Molecule Activators.Regeneration in the nervous system with erythropoietinEffects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study.mTOR: on target for novel therapeutic strategies in the nervous system.Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of α-synuclein oligomers and decrease of neurites.AMPK activation protects from neuronal dysfunction and vulnerability across nematode, cellular and mouse models of Huntington's disease.Mitochondrial biogenesis: a therapeutic target for neurodevelopmental disorders and neurodegenerative diseasesAMPKα1 knockout enhances nociceptive behaviors and spinal glutamatergic synaptic activities via production of reactive oxygen species in the spinal dorsal hornAlternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.A high fat diet alters metabolic and bioenergetic function in the brain: A magnetic resonance spectroscopy study.The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylationThe Modulation of Cardiac Contractile Function by the Pharmacological and Toxicological Effects of Urocortin2.Roles of AMP-activated protein kinase in Alzheimer's disease.Energy dysfunction in Huntington's disease: insights from PGC-1α, AMPK, and CKB.Involvement of 'stress-response' kinase pathways in Alzheimer's disease progression.Programming apoptosis and autophagy with novel approaches for diabetes mellitus.Activation of mTOR: a culprit of Alzheimer's disease?AMP-activated protein kinase and cAMP response element-binding protein activity are associated with distinct postoperative behavioral changes in rats.
P2860
Q26753053-EF0997A2-A5CE-4031-A41D-98475D98571EQ26864424-BF22DEDE-E147-4F75-8CD3-B09776D1E7EDQ28080679-5A5B78FB-545F-4979-9C9B-E4CE2149C3F9Q28081671-D74E801F-E26E-4CC7-B8BC-A15E2ADA1543Q28534586-4A47B01D-9DF4-40E8-8027-88A6DC523932Q28539100-3167B24E-8A87-4B3C-8D4D-5823990DD2D1Q33623924-B85564FA-5758-4550-80D9-825DC8F7DA87Q33689169-8BC68772-3834-4D2D-95DF-3094FF668885Q33706136-4C793433-DC03-48A1-B387-1099E4994A61Q33899674-43FA37FC-C83F-4C70-8825-B2F051A79AD8Q34123865-1316FFAA-C98F-46EB-946A-57CD2DEE74AEQ34603651-19836A5C-153C-4D17-AEE7-CBC859F8BF6FQ34622157-618441EB-B7B1-441E-8A8A-356AF79CD794Q34667762-5C2B1F35-31EF-429C-91CA-D2F678E27C68Q35183471-564F7B15-7F2D-4A3F-B4E7-C2A83A650F42Q35688894-55A07D63-2EF9-4345-9EAC-B35985B40061Q35695006-0022E269-11AF-427C-9112-213E19571629Q35733751-396AC53A-FA1B-4DDC-8DA0-D410A66D17EBQ35754213-ECAE1399-BCA1-4455-8DFE-3D411CAD87A5Q35813713-1EE61E8A-9820-4E7B-9D3F-27E62F80F534Q35905362-B0BB27E0-E70D-45F6-B076-F65F66B5B256Q35947388-FAE0162F-621E-4E7C-AB37-FCCFA5B5F0F3Q36182575-E7F0D4B8-A271-4C00-97BC-DD858A5597A6Q36247651-3A07ED9A-ACCF-4F2C-A36B-13A1679A2658Q36379186-BFE149D2-1DE7-4A7A-B76A-B481216B4FD3Q36501214-FBDA4E1B-4127-4C63-824B-41283EB76A97Q36604979-B1FE0FE6-39E6-40A4-9D59-2CF1521F0575Q36608838-F591B360-E294-4F96-91F4-82292977D401Q36771650-D0BB89D2-C216-41C6-BC4B-C83A85E006AEQ36867649-F6EF126A-47E5-493B-8538-2775A5CEB922Q36913723-38E1E1D1-F1B3-433F-B7B2-2DEABB0830DBQ36989464-54C5CC30-865E-467C-84F7-18CF7260CA1DQ37200468-BEB7497C-BDC5-438E-8289-80C6D3D9C0B0Q37228131-7F9176D3-80A4-4300-83F2-8EB41027CF28Q37988399-30499AE7-83E7-4750-AD94-96E2B86D0C9AQ38013005-59EDD758-CA11-43FF-AB34-A7D79E2EDCC8Q38202756-D41120DA-059D-4324-B3D4-69EE658447FBQ38367977-D4D63677-9D8B-4D9D-94DF-EE50848E245AQ38443497-0C64FE06-5F6F-430F-A268-613E303BFFD8Q38604460-FDA8B0A5-CDD9-4D3E-8765-331DC515CAA0
P2860
AMP-activated protein kinase: a potential player in Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
AMP-activated protein kinase: a potential player in Alzheimer's disease.
@en
AMP-activated protein kinase: a potential player in Alzheimer's disease.
@nl
type
label
AMP-activated protein kinase: a potential player in Alzheimer's disease.
@en
AMP-activated protein kinase: a potential player in Alzheimer's disease.
@nl
prefLabel
AMP-activated protein kinase: a potential player in Alzheimer's disease.
@en
AMP-activated protein kinase: a potential player in Alzheimer's disease.
@nl
P2860
P50
P1476
AMP-activated protein kinase: a potential player in Alzheimer's disease.
@en
P2093
Antero Salminen
Mikko Hiltunen
P2860
P304
P356
10.1111/J.1471-4159.2011.07331.X
P407
P577
2011-06-24T00:00:00Z